Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Koalaa | 2024 | Seed | $1.2M | London |
| Wayland Additive | 2024 | Series A | $5.3M | Huddersfield |
| Albus Health | 2024 | Series Unknown | Undisclosed | Oxford |
| Oxford Quantum Circuits | 2023 | Series B | $100.0M | Reading |
| Proxisense | 2023 | Series A | $1.3M | Oxford |
| Mach42 | 2023 | Seed | $5.5M | Oxford |
| NK:IO | 2023 | Seed | $1.5M | London |
| Cambridge Touch Technologies Ltd. | 2023 | Series B | $5.1M | Cambridge |
| Signaloid | 2023 | Seed | $3.7M | Cambridge |
| PharmEnable | 2023 | Seed | $7.5M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Koalaa | Seed | $1.2M | London, United Kingdom |
| 102 | Wayland Additive | Series A | $5.3M | Huddersfield, United Kingdom |
| 103 | Albus Health | Series Unknown | Undisclosed | Oxford, United Kingdom |
| 104 | Oxford Quantum Circuits | Series B | $100.0M | Reading, United Kingdom |
| 105 | Proxisense | Series A | $1.3M | Oxford, United Kingdom |
| 106 | Mach42 | Seed | $5.5M | Oxford, United Kingdom |
| 107 | NK:IO | Seed | $1.5M | London, United Kingdom |
| 108 | Cambridge Touch Technologies Ltd. | Series B | $5.1M | Cambridge, United Kingdom |
| 109 | Signaloid | Seed | $3.7M | Cambridge, United Kingdom |
| 110 | PharmEnable | Seed | $7.5M | Cambridge, United Kingdom |
Koalaa offers comfy, soft prosthetic arms and personalized support, for babies, kids, and adults.
Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing.
A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.
Oxford Quantum Circuits develops quantum computers designed for breakthrough discoveries.
Proxisense has developed extreme environment proximity sensors and fluid contamination systems.
Mach42 is a University of Oxford spin-out commercializing new machine learning technology.
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.
Pressure Sensitive Multi-Touch for Next-Generation Smart Devices including Smartphones, Tablets, Automotive and Industrial
Signaloid provides hardware and cloud-based compute platforms for computing workloads ranging from robotics to quantitative finance
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
Covatic is the use of mobile based algorithms to bring smart personalisation to apps.
Inductosense is developing wireless, battery-free, sensors that can be permanently fixed.
TextMine is the end-to-end AI powered knowledge base for your business critical documents.
Bonnet streamlines EV charging by offering one app for drivers and businesses to access any public charger.
Quantum Motion is building a universal quantum computer in Silicon, using CMOS compatible processes.
Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
Xerion Healthcare is the technology commercialization company of University of Oxford.
BibliU provides colleges and universities with digital content management, automation, and an analytics platform.
Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials.
iKVA is an AI knowledge management company that helps users with data analytics and decision making solutions.
DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.
Helio Display Materials offers foundational materials for the new wave of display innovation driven by color conversion.
Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
8power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications.
Parkwalk Advisors has invested in 144 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Parkwalk Advisors's top investment sectors include Software, Biotechnology, Information Technology, Health Care, Artificial Intelligence (AI). The firm invests across 40 different industry categories.
Among tracked funding rounds, Oxford Quantum Circuits received $100.0M in a Series B round. Parkwalk Advisors's total known invested capital is $1.1B.
Parkwalk Advisors's average investment size is $12.7M across its portfolio of 144 companies.
Recent Parkwalk Advisors portfolio additions include Koalaa, Wayland Additive, Albus Health, Oxford Quantum Circuits, Proxisense. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors